Samuel Earl HOPKINS;Yves Joseph Ribeill;Bernard Scorneaux
发明人:
Samuel Earl HOPKINS,Yves Joseph Ribeill,Bernard Scorneaux
申请号：
US13349251
公开号：
US20120208746A1
申请日:
2012.01.12
申请国别(地区):
US
年份:
2012
代理人:
摘要：
Methods of predicting the response in a patient infected with hepatitis C virus (HCV) to a treatment regime involving the use of a cyclophilin-binding compound are described which provide for improvements in treatments, pharmaceutical compositions, dosing regimen, assays, kits, and other aspects of the art.
